Fidelity Investments’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.4K | Sell |
5,881
-503,701
| -99% | -$4.83M | ﹤0.01% | 3843 |
|
|
2025
Q1 | $3.2M | Sell |
509,582
-291,819
| -36% | -$1.83M | ﹤0.01% | 2302 |
|
|
2024
Q4 | $6.51M | Sell |
801,401
-502,713
| -39% | -$4.08M | ﹤0.01% | 2072 |
|
|
2024
Q3 | $23.6M | Buy |
1,304,114
+1,301,458
| +49,001% | +$23.5M | ﹤0.01% | 1652 |
|
|
2024
Q2 | $27.4K | Buy |
2,656
+572
| +27% | +$5.89K | ﹤0.01% | 3919 |
|
|
2024
Q1 | $22.1K | Sell |
2,084
-1,249
| -37% | -$13.3K | ﹤0.01% | 3969 |
|
|
2023
Q4 | $30.4K | Buy |
3,333
+1,444
| +76% | +$13.2K | ﹤0.01% | 3745 |
|
|
2023
Q3 | $19.6K | Sell |
1,889
-35,435
| -95% | -$367K | ﹤0.01% | 3816 |
|
|
2023
Q2 | $534K | Buy |
37,324
+36,556
| +4,760% | +$523K | ﹤0.01% | 2633 |
|
|
2023
Q1 | $5.48K | Buy |
768
+73
| +11% | +$521 | ﹤0.01% | 4362 |
|
|
2022
Q4 | $7.8K | Sell |
695
-520
| -43% | -$5.83K | ﹤0.01% | 4104 |
|
|
2022
Q3 | $13K | Buy |
1,215
+837
| +221% | +$8.96K | ﹤0.01% | 3993 |
|
|
2022
Q2 | $3K | Sell |
378
-105
| -22% | -$833 | ﹤0.01% | 4482 |
|
|
2022
Q1 | $7K | Buy |
+483
| New | +$7K | ﹤0.01% | 4346 |
|
|
2021
Q4 | – | Sell |
-154,200
| Closed | -$4.95M | – | 4801 |
|
|
2021
Q3 | $4.95M | Buy |
+154,200
| New | +$4.95M | ﹤0.01% | 2372 |
|